Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China
Titel:
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China
Auteur:
Gu, Xiaohua Zhang, Qiang Chu, Yun-Bo Zhao, Yi-Yang Zhang, Yan-Jun Kuo, David Su, Betty Wu, Bin